Sol gel technologies q2 revenue $1.1 million

Sol-gel technologies reports second quarter 2020 financial results and corporate update.q2 revenue $1.1 million.q2 revenue estimate $3.1 million -- refinitiv ibes data.new drug application for epsolay submitted; twyneo new drug application on track for 2h 2020.qtrly loss per ordinary share of $0.31.

SLGL Ratings Summary

SLGL Quant Ranking